These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 12722172
1. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Uchiyama T, Sakakibara R, Hattori T, Yamanishi T. Mov Disord; 2003 May; 18(5):573-8. PubMed ID: 12722172 [Abstract] [Full Text] [Related]
2. Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease. Uchiyama T, Sakakibara R, Yamamoto T, Ito T, Yamaguchi C, Awa Y, Yano M, Yanagisawa M, Kobayashi M, Higuchi Y, Ichikawa T, Yamanishi T, Hattori T, Kuwabara S. Mov Disord; 2009 Dec 15; 24(16):2386-90. PubMed ID: 19908315 [Abstract] [Full Text] [Related]
3. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. Hironishi M, Miwa H, Kondo T. No To Shinkei; 2002 Feb 15; 54(2):127-32. PubMed ID: 11889758 [Abstract] [Full Text] [Related]
4. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Winge K, Werdelin LM, Nielsen KK, Stimpel H. Neurourol Urodyn; 2004 Feb 15; 23(7):689-96. PubMed ID: 15382192 [Abstract] [Full Text] [Related]
5. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Brusa L, Petta F, Pisani A, Moschella V, Iani C, Stanzione P, Miano R, Finazzi-Agrò E. Neurology; 2007 May 01; 68(18):1455-9. PubMed ID: 17470746 [Abstract] [Full Text] [Related]
6. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease. Liu Z, Uchiyama T, Sakakibara R, Yamamoto T. Int Urol Nephrol; 2015 May 01; 47(5):751-7. PubMed ID: 25792006 [Abstract] [Full Text] [Related]
14. [Disturbance of micturition in Parkinson's disease]. Sakakibara R, Uchiyama T, Yoshiyama M, Hattori T. No To Shinkei; 2001 Nov 01; 53(11):1009-14. PubMed ID: 11761908 [No Abstract] [Full Text] [Related]
15. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease. Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL. Mov Disord; 2008 Sep 15; 23(12):1696-700. PubMed ID: 18649391 [Abstract] [Full Text] [Related]
16. [Urinary incontinence in patients with Parkinson syndrome]. Jost WH, Schimrigk K. Wien Klin Wochenschr; 1996 Sep 15; 108(10):296-302. PubMed ID: 8711916 [Abstract] [Full Text] [Related]
17. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. Araki I, Kitahara M, Oida T, Kuno S. J Urol; 2000 Nov 15; 164(5):1640-3. PubMed ID: 11025724 [Abstract] [Full Text] [Related]
18. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Kuo HC. Urology; 2004 May 15; 63(5):868-72. PubMed ID: 15134967 [Abstract] [Full Text] [Related]
19. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? Roth B, Studer UE, Fowler CJ, Kessler TM. J Urol; 2009 May 15; 181(5):2209-13. PubMed ID: 19296974 [Abstract] [Full Text] [Related]
20. Idiopathic Parkinson's disease patients at the urologic clinic. Ragab MM, Mohammed ES. Neurourol Urodyn; 2011 Sep 15; 30(7):1258-61. PubMed ID: 21404318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]